Fagundo AB et al. |
Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans. |
2013 |
PLoS ONE |
pmid:23840456
|
Sergi M et al. |
Determination of the two major endocannabinoids in human plasma by μ-SPE followed by HPLC-MS/MS. |
2013 |
Anal Bioanal Chem |
pmid:22847477
|
Ueda N et al. |
Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways. |
2013 |
FEBS J. |
pmid:23425575
|
Sugaya Y et al. |
The endocannabinoid 2-arachidonoylglycerol negatively regulates habituation by suppressing excitatory recurrent network activity and reducing long-term potentiation in the dentate gyrus. |
2013 |
J. Neurosci. |
pmid:23426686
|
DiPatrizio NV et al. |
Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats. |
2013 |
FASEB J. |
pmid:23463697
|
Keimpema E et al. |
Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23319656
|
Shimizu T et al. |
Stimulatory and inhibitory roles of brain 2-arachidonoylglycerol in bombesin-induced central activation of adrenomedullary outflow in rats. |
2013 |
J. Pharmacol. Sci. |
pmid:23386378
|
Tchantchou F and Zhang Y |
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury. |
2013 |
J. Neurotrauma |
pmid:23151067
|
Alhouayek M et al. |
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24101490
|
Neumeister A et al. |
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. |
2013 |
Mol. Psychiatry |
pmid:23670490
|
Jain T et al. |
Diacylglycerol lipaseα (DAGLα) and DAGLβ cooperatively regulate the production of 2-arachidonoyl glycerol in autaptic hippocampal neurons. |
2013 |
Mol. Pharmacol. |
pmid:23748223
|
Citraro R et al. |
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. |
2013 |
Neuropharmacology |
pmid:23206503
|
Signorello MG et al. |
The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets. |
2013 |
Biochimie |
pmid:23702422
|
Higgins A et al. |
Differential modulation of nociceptive versus non-nociceptive synapses by endocannabinoids. |
2013 |
Mol Pain |
pmid:23725095
|
Almeida-Santos AF et al. |
Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray. |
2013 |
Behav. Brain Res. |
pmid:23714073
|
Perez-Rosello T et al. |
Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis. |
2013 |
J. Neurosci. |
pmid:23719795
|
Yang Y et al. |
Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury. |
2013 |
Cell. Signal. |
pmid:23142606
|
Guindon J et al. |
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. |
2013 |
Pharmacol. Res. |
pmid:23127915
|
Frazier CJ |
Preformed vs. on-demand: molecular economics of endocannabinoid signalling. |
2013 |
J. Physiol. (Lond.) |
pmid:24085490
|
Starowicz K et al. |
Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism. |
2013 |
PLoS ONE |
pmid:23573230
|
Subbanna S et al. |
Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits. |
2013 |
J. Neurosci. |
pmid:23575834
|
Morgan CJ et al. |
Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms. |
2013 |
Br J Psychiatry |
pmid:23580381
|
Bisogno T et al. |
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects. |
2013 |
Br. J. Pharmacol. |
pmid:23072382
|
Blankman JL and Cravatt BF |
Chemical probes of endocannabinoid metabolism. |
2013 |
Pharmacol. Rev. |
pmid:23512546
|
Berge K et al. |
Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men. |
2013 |
Lipids Health Dis |
pmid:23706001
|
Zygmunt PM et al. |
Monoacylglycerols activate TRPV1--a link between phospholipase C and TRPV1. |
2013 |
PLoS ONE |
pmid:24312564
|
Wang R et al. |
Identification of palmitoyl protein thioesterase 1 in human THP1 monocytes and macrophages and characterization of unique biochemical activities for this enzyme. |
2013 |
Biochemistry |
pmid:24083319
|
Ikeda H et al. |
Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice. |
2013 |
Neuroscience |
pmid:23892011
|
Yuan S and Burrell BD |
Nonnociceptive afferent activity depresses nocifensive behavior and nociceptive synapses via an endocannabinoid-dependent mechanism. |
2013 |
J. Neurophysiol. |
pmid:24027102
|
Hill MN et al. |
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. |
2013 |
Psychoneuroendocrinology |
pmid:24035186
|
Blasio A et al. |
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala. |
2013 |
Neuropsychopharmacology |
pmid:23793355
|
Malenczyk K et al. |
CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release. |
2013 |
J. Biol. Chem. |
pmid:24089517
|
Brocato B et al. |
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity. |
2013 |
Placenta |
pmid:24008071
|
Baur R et al. |
Molecular analysis of the site for 2-arachidonylglycerol (2-AG) on the β₂ subunit of GABA(A) receptors. |
2013 |
J. Neurochem. |
pmid:23600744
|
Fonseca BM et al. |
Endogenous cannabinoids revisited: a biochemistry perspective. |
2013 Apr-May |
Prostaglandins Other Lipid Mediat. |
pmid:23474290
|
Pascual AC et al. |
Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism. |
2013 Mar-Apr |
Biofactors |
pmid:23281018
|
Smaga I et al. |
Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures. |
2014 |
Neurotox Res |
pmid:24652522
|
Kohnz RA and Nomura DK |
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. |
2014 |
Chem Soc Rev |
pmid:24676249
|
Pastor A et al. |
Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs. |
2014 |
J. Lipid Res. |
pmid:24610889
|
Pérez-Morales M et al. |
2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation. |
2014 |
Neuroreport |
pmid:25356522
|
Morena M et al. |
Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25489086
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
Sun LJ et al. |
Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication. |
2014 |
Int. J. Infect. Dis. |
pmid:24704332
|
Basavarajappa BS et al. |
Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice. |
2014 |
Hippocampus |
pmid:24648181
|
Aaltonen N et al. |
Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice. |
2014 |
Eur J Pharm Sci |
pmid:24012970
|
Brantl SA et al. |
Activation of platelets by the endocannabinoids 2-arachidonoylglycerol and virodhamine is mediated by their conversion to arachidonic acid and thromboxane A2, not by activation of cannabinoid receptors. |
2014 |
Platelets |
pmid:24102401
|
Pertwee RG |
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. |
2014 |
Proc Nutr Soc |
pmid:24135210
|
Burston JJ and Woodhams SG |
Endocannabinoid system and pain: an introduction. |
2014 |
Proc Nutr Soc |
pmid:24148358
|
Desroches J et al. |
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CBâ‚ and CBâ‚‚ receptors. |
2014 |
Neuropharmacology |
pmid:24148808
|
Yang K et al. |
Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus. |
2014 |
Hippocampus |
pmid:25087967
|